Valuation: CanSino Biologics Inc.

Market Cap 1.2TCr 1.41TCr 180.35Cr 161.26Cr 149.2Cr 135.09Cr 252.83Cr 17TCr 256.97Cr 1.8TCr 710.18Cr 8.97TCr 676.87Cr 662.41Cr 28TCr P/E 2026 *
56.6x
P/E 2027 * 19x
Enterprise Value 1.21TCr 1.42TCr 180.71Cr 161.59Cr 149.5Cr 135.36Cr 253.34Cr 17TCr 257.49Cr 1.8TCr 711.6Cr 8.99TCr 678.22Cr 663.73Cr 28TCr EV / Sales 2026 *
8.37x
EV / Sales 2027 * 6.87x
Free-Float
39.57%
Yield 2026 *
-
Yield 2027 * -
1 day+2.33%
1 week-4.35%
Current month-20.63%
1 month-4.54%
3 months+24.04%
6 months-11.69%
Current year-16.95%
1 week 26.44
Extreme 26.44
31.2
1 month 26.44
Extreme 26.44
40.84
Current year 19.22
Extreme 19.22
41.64
1 year 19.22
Extreme 19.22
47.8
3 years 14.8
Extreme 14.8
56.55
5 years 14.8
Extreme 14.8
222.8
10 years 14.8
Extreme 14.8
450
Manager TitleAgeSince
Corporate Officer/Principal 66 21/02/2024
Chief Tech/Sci/R&D Officer 53 13/01/2009
Chief Executive Officer 62 13/01/2009
Director TitleAgeSince
Chairman 62 13/01/2009
Director/Board Member 63 22/06/2018
Director/Board Member 44 11/10/2021
Date Insider Type Main position Quantity % Market Cap. Importance
26/08/25 Sell

Director

4,600 0.0069%
26/09/24 Other

Chief Executive Officer

20,000 0.0151%
09/09/24 Other

Founder

30,000 0.0226%
Change 5-day change 1-year change 3-year change Capi.($)
+2.33%-4.35%-31.73%+28.04% 176.55Cr
+0.45%+1.76%+54.96%+118.11% 1,13500Cr
+0.94%+4.20%+39.86%+75.69% 64TCr
+0.39%+0.46%+25.77%+97.40% 50TCr
+1.43%+4.56%+46.20%+66.91% 38TCr
-3.21%-3.66%+60.72%+35.68% 36TCr
-0.41%+2.23%+22.48%+48.54% 29TCr
+0.23%+3.28%+2.57%+21.89% 27TCr
+1.22%+2.81%+52.40%+63.37% 24TCr
+1.70%+1.60%+31.21%+102.44% 19TCr
Average +0.45%+0.79%+30.44%+65.81% 40.05TCr
Weighted average by Cap. +0.26%+1.63%+41.37%+81.01%

Financials

2026 *2027 *
Net sales 144.03Cr 169.35Cr 22Cr 19Cr 18Cr 16Cr 30Cr 2.05TCr 31Cr 214.9Cr 85Cr 1.07TCr 81Cr 79Cr 3.4TCr 181.22Cr 213.07Cr 27Cr 24Cr 22Cr 20Cr 38Cr 2.58TCr 39Cr 270.38Cr 106.95Cr 1.35TCr 101.93Cr 100Cr 4.28TCr
Net income 11Cr 13Cr 1.6Cr 1.43Cr 1.33Cr 1.2Cr 2.25Cr 152.57Cr 2.29Cr 16Cr 6.31Cr 80Cr 6.02Cr 5.89Cr 252.67Cr 32Cr 38Cr 4.83Cr 4.32Cr 4Cr 3.62Cr 6.77Cr 459.46Cr 6.88Cr 48Cr 19Cr 240.32Cr 18Cr 18Cr 760.9Cr
Net Debt 2.4Cr 2.82Cr 36L 32.19L 29.78L 26.97L 50.47L 34Cr 51.3L 3.58Cr 1.42Cr 18Cr 1.35Cr 1.32Cr 57Cr 42Cr 49Cr 6.22Cr 5.56Cr 5.15Cr 4.66Cr 8.72Cr 591.89Cr 8.86Cr 62Cr 24Cr 309.58Cr 23Cr 23Cr 980.21Cr
Projected Income Statement - Annual - CanSino Biologics Inc.
Logo CanSino Biologics Inc.
CanSino Biologics Inc is a China-based company primarily engaged in the research and development, production, and commercialization of human vaccine products. The Company’s products and product pipeline under research include multiple vaccine varieties such as meningitis, pneumonia, diphtheria, tetanus, and pertussis (DPT), coronavirus disease 2019 (COVID-19), Ebola virus disease, poliomyelitis, herpes zoster, tuberculosis and others. The Company is also engaged in the research and development of pharmaceutical production processes. The Company conducts its business in the domestic and overseas markets.
Employees
1,175
Date Price Change Volume
26/26/26 HK$29.00 +2.33% 32,09,400
23/26/23 HK$28.34 -2.07% 36,75,997
22/26/22 HK$28.94 -3.85% 24,67,146
21/26/21 HK$30.10 +2.73% 39,76,153
20/26/20 HK$29.30 -3.36% 35,48,457
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - CanSino Biologics Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
24.66CNY
Average target price
40.47CNY
Spread / Average Target
+64.07%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - CanSino Biologics Inc.
  1. Stock Market
  2. Stocks
  3. 6185 Stock